CARISSA MITCHELL: Open Payments
NPI 1053081703 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 18 payments from 9 companies in 2025. Trend: 2023 $362 · 2024 $134 · 2025 $592
Food & beverage: $493Education: $99
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $195 |
| Daiichi Sankyo Inc. | 3 | $177 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $23 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: Trodelvy, Enhertu, KEYTRUDA, KEYTRUDA QLEX, DARZALEX, XALKORI, LYNOZYFIC, Orserdu.
Industry payments across OH — which companies pay providers there.
